Welcome to LookChem.com Sign In|Join Free

CAS

  • or

681821-72-7

Post Buying Request

681821-72-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

681821-72-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 681821-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,1,8,2 and 1 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 681821-72:
(8*6)+(7*8)+(6*1)+(5*8)+(4*2)+(3*1)+(2*7)+(1*2)=177
177 % 10 = 7
So 681821-72-7 is a valid CAS Registry Number.

681821-72-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2',3'-dideoxy-5-iodo-6-methoxyuridine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:681821-72-7 SDS

681821-72-7Downstream Products

681821-72-7Relevant articles and documents

Discovery of a New Family of Inhibitors of Human Cytomegalovirus (HCMV) Based upon Lipophilic Alkyl Furano Pyrimidine Dideoxy Nucleosides: Action via a Novel Non-Nucleosidic Mechanism

McGuigan, Christopher,Pathirana, Ranjith N.,Snoeck, Robert,Andrei, Graciela,De Clercq, Erik,Balzarini, Jan

, p. 1847 - 1851 (2007/10/03)

Following our discovery of the potent anti-varicella zoster virus action of lipophilic alkyl furano pyrimidine 2′-deoxynucleosides, we now report that 2′,3′-dideoxy sugar analogues are devoid of anti-VZV activity but are potent and selective inhibitors of human cytomegalovirus (HCMV). The present compounds are active in vitro at ca. 1 μM with cytotoxicity only above 200 μM. Importantly, we have discovered that the new agents do not act as nucleoside analogues, despite their nucleosidic structure, and time of addition studies revealed that the compounds may inhibit HCMV at an event in the replication cycle of the virus that precedes DNA synthesis. They represent new leads in the discovery of improved therapies for HCMV, particularly in view of their novel mechanism of action.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 681821-72-7